-
Published 6/4/2024
Labban M, Stone BV, Steele GL, Salinas KE, Agudile E, Katz MH, Rihan-Porter N, Reich AJ, Cole AP, Landers S, Trinh QD. A qualitative approach to understanding the drivers of unequal receipt of definitive therapy for Black men with prostate cancer in Massachusetts. Cancer. 2024 Oct 15; 130 Suppl 20:3590-3601. PMID: 38837334.
-
Published 4/11/2022
Mori JO, Shafran JS, Stojanova M, Katz MH, Gignac GA, Wisco JJ, Heaphy CM, Denis GV. Novel forms of prostate cancer chemoresistance to successful androgen deprivation therapy demand new approaches: Rationale for targeting BET proteins. Prostate. 2022 Jun; 82(10):1005-1015. PMID: 35403746.
-
Published 3/9/2021
Ionson A, Monfared SHB, Ursiny M, Katz M, Wang D, Babayan R, Wason S. Economic Evaluation of 1470?nm Diode Laser Enucleation vs Bipolar Transurethral Resection of the Prostate. J Endourol. 2021 08; 35(8):1204-1210. PMID: 33499745.
-
Published 1/5/2021
Carpinito G, Shepherd S, Wang DS, Katz MH, Wason SEL. Reply by Authors. Urol Pract. 2021 Mar; 8(2):283. PMID: 37145649.
-
Published 12/1/2020
Poulson MR, Helrich SA, Kenzik KM, Dechert TA, Sachs TE, Katz MH. The impact of racial residential segregation on prostate cancer diagnosis and treatment. BJU Int. 2021 06; 127(6):636-644. PMID: 33166036.